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ABSTRACT
Background: There are little data on the prevalence of serological markers of hepatitis 
B and hepatitis C viruses in pregnant women in Iran.
Objectives: This study was designed to determine the prevalence of hepatitis B virus 
(HBV) and hepatitis C virus (HCV) infection among pregnant women in Lorestan, west 
of Iran.
Patients and Methods: Serum samples of 827 pregnant women who lived in rural (36.8%) 
and urban areas (63.2%) of Lorestan were collected during 2007-2008. Data were ob-
tained through questionnaires. Samples were ﬁrst screened for anti-HCV and anti-HBc 
by ELISA. Those who were positive for anti-HBc were tested for HBsAg.
Results: Anti-HBc was found in 28 of 827 pregnant women (overall prevalence, 3.4%; 14 
of 523 in urban areas, 2.7%; 14 of 304 in rural areas, 4.6%). Of the 28 positive samples, 6 
(0.7%) were positive for HBs-Ag. Only 2 samples (0.2%) were anti-HCV-positive.
Conclusions: These results underscore the need for prenatal screening for HBV infec-
tion in pregnant women and treatment of newborns from HBsAg-positive mothers. 
More studies are needed to identify risk factors of HCV infection and highlight the 
importance of HCV screening and treatment programs.
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  Implication for health policy/practice/research/medical education:
The authors mentioned that low prevalence of HBV and HCV in this region establish a national program for regular screening of all 
pregnant women. Most pregnant women are asymptomatic and clinically disease free and they might not be aware that they are 
infected and can transmit their infection to newborns. Therefore, prenatal screening for HBV infection in pregnant women and treat-
ment of newborns from HBsAg-positive mothers and also identify risk factors of HCV infection is nessecerry.
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1. Background
Hepatitis B virus infection (HBV) and hepatitis C virus 
infection (HCV) are serious public health problems 
worldwide; an estimated 170 and 400 million persons 
suﬀer from these infections (1, 2). HBV and HCV are a 
contagious diseases in Iran that can be transmitted verti-
cally from mothers to their neonates or horizontally by 
blood products and body secretions (3, 4). According to 
the latest data in Iran, 1.2% to 9.7% of the general popu-
lation has acquired hepatitis B surface antigen (HBs Ag) 
(about 1.5-2.5 million people), and 0.12% to 0.89% has anti-
hepatitis C virus, which corresponds to about 0.5 mil-
lion chronic carriers of hepatitis C (3, 5-7). Chronic HBV 
infection at birth occurs in approximately 90% of infants 
who are born to HBsAg- and HBeAg-positive mothers (8). 
Even if they are not infected during pregnancy, children Hepat Mon. 2011;11(9):736-739
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of HBV-infected mothers have a high risk of acquiring 
HBV infection by horizontal transmission during the 
ﬁrst years of life (9). On the other hand, the range of 
transmission of HCV from mother to child during preg-
nancy is between 0% and 15% (10). The prevalence of HBV 
among pregnant women worldwide is approximately 5% 
(11), ranging from 0.6% in low-endemic regions to > 20% 
in high-endemic areas in the Far East and Africa (11). In 
contrast, the prevalence of HCV among pregnant women 
worldwide is between 1% and 8% (12). 
2. Objectives
There are little data on the prevalence of serological 
markers of HBV and HCV among pregnant women in 
Iran. Thus, the aim of the present study was to determine 
the prevalence of HBV and HCV infection among preg-
nant women who attended the reproduction section of 
rural and urban health care centers in Lorestan province, 
west of Iran, to identify target groups for postpartum im-
munization.
3. Patients and Methods
3.1. Population
In this cross-sectional study, we recruited all pregnant 
women who attended the reproduction section of rural 
and urban health care centers in Lorestan province, west 
of Iran, between 2007 and 2008. Those who did not wish 
to participate in this project were excluded from study. Of 
827 pregnant women, 304 (36.8%) and 523 (63.2%) samples 
were collected from rural and urban areas, respectively. 
The subjects had a history of spontaneous deliveries, 
miscarriages, and previous successful pregnancies. The 
purpose and procedures of the study were explained to 
all participants by a trained researcher, and written in-
formed consent was obtained from all subjects. Partici-
pant information, including sociodemographic infor-
mation, clinical manifestation, behavioral data, age, job, 
prison history, tattooing, and IV drug abuse, were gath-
ered. The study was approved by the Institutional Ethics 
Committee of the Research Center for Gastroenterology 
and Liver Disease (RCGLD), Shahid Beheshti University of 
Medical Sciences.
3.2. Blood Sample
To obtain serum, blood samples were taken and centri-
fuged to separate the serum. Serum samples were trans-
ferred to RCGLD under cold conditions by airplane and 
stored at -20°C. Samples were ﬁrst screened for anti-HBc 
and anti-HCV using commercially available ELISA kits 
(DIA PRO Diagnostic Bioprobes, Srl., Italy). Those who 
were positive for anti-HBc were tested for HBsAg (ELISA 
kits DIA PRO Diagnostic Bioprobes, Srl., Italy). 
3.3. Statistical Analysis
SPSS, version 15.0, was used for descriptive statistics. We 
also used corrected χ² test or Fisher’s exact test to com-
pare percentages, and P < 0.05 was considered statistic-
ally signiﬁcant. 
4. Results
Eight hundred twenty seven pregnant women with 
mean age of 26.1 ± 5.4 (mean ± SD) years (range: 13-42 
years) and mean gestational period of 5.5 ± 2.3 months, 
were studied. Anti-HBc was found in 28 of the 827 women. 
There was no diﬀerence between mean age of anti-HBc-
No,    
(n = 827)
Anti-HBc positive, 
No. (%), (n = 28)
P value HBs Ag positive, 
No. (%), (n = 6)
P value Anti-HCV positive, 
No. (%), (n = 2)
P value
Age, y 0.81 0.89 0.56
≤ 20
21-30
≥ 31
127
526
174
4 (3.1)
20 (3.8)
4 (2.3)
1 (0.8%)
3 (0.6%)
2 (1.1%)
1 (0.8%)
1 (0.2%)
0 (0%)
Location 0.14 0.86 0.53
Urban 
Rural
523
304
14 (2.7)
14 (4.6)
4 (0.8%)
2 (0.7%)
2 (0.4%)
0 (0%)
Educational level 0.87 0.57 0.63
Illiterate
Under Diploma
Diploma
University Degree
41
308
357
121
1 (2.4)
8 (2.6)
14 (3.9)
5 (4.1)
1 (2.4%)
3 (1%)
1 (0.3%)
1 (0.8%)
0 (0%)
0 (0%)
2 (0.6%)
0 (0%)
Occupation 0.62 0.63 0.78
Housekeeper
Employee
796
31
28 (3.5)
0 (0)
6 (0.8%)
0 (0%)
2 (0.3%)
0 (0%)
History of miscarriage 0.69 0.49 0.83
Yes
No
130
697
6 (4.6)
22 (3.2)
2 (1.5%)
4 (0.6%)
0 (0)
2 (0.3%)
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positive patients and -negative subjects (Table). Of 28 
anti-HBc-positive patients, 6 (0.7%) were positive for HBs-
Ag; this diﬀerence was not signiﬁcant between urban 
and rural populations. 
Of 827 pregnant women, 2 samples (0.2%) were anti-
HCV-positive. These patients were also HBs-Ag-positive 
and from urban areas, and none had a history of miscar-
riage (Table). No anti-HBc-, HBs-Ag-, or anti-HCV-positive 
subject had a history of tattooing or being in prison or 
was an IV drug user. There were no signiﬁcant diﬀer-
ences in age, history of miscarriage, occupation, educa-
tion level, income, or other general socioeconomic par-
ameters between HBs-Ag positive and negative as well as 
anti-HCV positive and negative (P > 0.05).
5. Discussion
Chronic liver diseases are an important health chal-
lenge worldwide, wherein HBV or HCV infection is the 
main cause of liver insuﬃciency with diﬀerent verities 
in all over the world (13). The seroprevalence of HBsAg 
in our study (0.7%) was lower than the rate of HBsAg 
positivity in pregnant women in diﬀerent parts of Iran, 
including Zahedan (6.5%) (14), Qazvin (3.4%) (15), Bonab 
(3.2%) (16), Kerman (2.3%) (17), Ahwaz (1.7%) (18), Rafsanjan 
(1.3%) (19), and Yazd (0.84%) (20), but was higher than in 
Kashan (0.35%) (21). Our rates are also lower than those 
for North Africa and Middle Eastern countries, in which 
the prevalence of HBsAg among pregnant women is 1.4% 
to 20% (14). HBsAg positivity among pregnant women in 
urban areas in the US is 0.1% in Hispanics to 1% in non-His-
panic blacks; notably, HBsAg positivity is more prevalent 
among Asians (5.8%) (22). 
Our study shows that the seroprevalence of anti-HCV is 
0.2%, which is lower than a survey by Motlagh ME et al. 
in Ahvaz (6.25%) (23), while our study result was compat-
ible with those of Brazilian (0.2%) and Canadian studies 
(0.5%) (24, 25). The limitations of our study are that we 
did not investigate a similar population of nonpregnant 
women to compare the ﬁndings and surveyed a single 
city in this province.
In conclusion, HBV and HCV are not prevalent among 
pregnant women in Lorestan province compared with 
the rest of the country. However, this low prevalence jus-
tiﬁes the establishment of a national program for regu-
lar screening of all pregnant women. Because most preg-
nant women are asymptomatic and clinically disease-
free, they might not be aware that they are infected and 
can transmit their infection to newborns. 
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